ScholarLens Back to search
2011•Unpublished venueRequires access

Safety of structured triglyceride used in treatment of hyperbilirubinemia patients:A comparative study

Feihu Zhou

Open publisher page 3 citations

Abstract

Objective To compare the safety of structured triglyceride(STG) and physically mixed medium chain triglyceride/long chain triglyceride(MCT/LCT) used in treatment of hyperbilirubinemia patients.Methods Fifty hyperbilirubinemia patients admitted to our hospital from 2008 to 2009 with a serum total bilirubin of 200-400μmol/L on the postoperative day were divided into STG group(n=25) and MCT/LCT group(n=5).Their parenteral STB and MCT/LCT nutrition in patients for≥5 days was retrospectively analyzed.Results The ALT,AST,AKP,γ-GT and bilirubin levels were significantly lower in the two groups 1 and 5 days after the STG and MCT/LCT were used than before they were used(P0.05).However,no significant difference was found in triglyceride between the two groups(P0.05).Conclusion The effects of STG and MCT/LCT are not significantly different on the liver function of hyperbilirubinemic patients.

About this research paper

What this paper is about

Objective To compare the safety of structured triglyceride(STG) and physically mixed medium chain triglyceride/long chain triglyceride(MCT/LCT) used in treatment of hyperbilirubinemia patients.Methods Fifty hyperbilirubinemia patients admitted to our hospital from 2008 to 2009 with a serum total bilirubin of 200-400μmol/L on the postoperative day were divided into STG group(n=25) and MCT/LCT group(n=5).Their parenteral STB and MCT/LCT nutrition in patients for≥5 days was retrospectively analyzed.Results The ALT,AST,AKP,γ-GT and bilirubin levels were significantly lower in the two groups 1 and 5 days after the STG and MCT/LCT were used than before they were used(P0.05).However,no significant difference was found in triglyceride between the two groups(P0.05).Conclusion The effects of STG and MCT/LCT are not significantly different on the liver function of hyperbilirubinemic patients.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the safety of structured triglyceride(STG) and physically mixed medium chain triglyceride/long chain triglyceride(MCT/LCT) used in treatment of hyperbilirubinemia patients.Methods Fifty hyperbilirubinemia patients admitted to our hospital from 2008 to 2009 with a serum total bilirubin of 200-400μmol/L on the postoperative day were divided into STG group(n=25) and MCT/LCT group(n=5).Their parenteral STB and MCT/LCT nutrition in patients for≥5 days was retrospectively analyzed.Results The ALT,AST,AKP,γ-GT and bilirubin levels were significantly lower in the two groups 1 and 5 days after the STG and MCT/LCT were used than before they were used(P0.05).However,no significant difference was found in triglyceride between the two groups(P0.05).Conclusion The effects of STG and MCT/LCT are not significantly different on the liver function of hyperbilirubinemic patients.

Key concepts: Triglyceride, Medium-chain triglyceride, Medicine, Bilirubin, Gastroenterology, Internal medicine, Parenteral nutrition, Significant difference

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Safety of structured triglyceride used in treatment of hyperbilirubinemia patients:A comparative study — Research Paper | ScholarLens